meta_pixel
Tapesearch Logo
Log in
Slate News

TBD | What's Taking the FDA So Long?

Slate News

Slate Podcasts

News, News Commentary, Politics

4.56K Ratings

🗓️ 13 August 2021

⏱️ 24 minutes

🧾️ Download transcript

Summary

Experts say that a “fully approved” designation for the vaccines could have sweeping effects. Broader vaccination mandates, inclusion for new age groups, and reassurance for those hesitant to take a vaccine without the designation. As calls for approval grow louder and more urgent, the Food and Drug Administration is yet to give its blessing. What’s happening inside the FDA as they work toward this milestone?


Guest: Sarah Owermohle, health care reporter at Politico 


Host:


Lizzie O’Leary


Hosted on Acast. See acast.com/privacy for more information.

Transcript

Click on a timestamp to play from that location

0:00.0

Lately, I've been thinking about how certain terms from the pandemic are just part of our vocabulary now.

0:11.0

Words and phrases that were utterly unfamiliar to us in 2019.

0:16.0

Super spreader, social distancing, PPE.

0:19.0

And one of those for me is emergency use authorization or EUA.

0:25.1

You know, I realized that I as a reporter have been using the term emergency use authorization

0:32.7

and EUA a lot since December.

0:35.6

And yet at the same time, I'm not sure I could actually define what it

0:40.8

means. Can you define it? So emergency use authorization is something that came about in 2005,

0:48.6

so it's relatively recent to the history of drugs and regulation. Sarah Overmall is not new to the term.

0:55.8

She covers health care for Politico.

0:57.5

Right now, she's mostly focused on COVID and vaccines.

1:01.1

It came about for an anthrax vaccine

1:03.4

that the armed services needed because of biological threats

1:06.8

and has been used since then for desperately needed vaccines

1:09.9

or treatments for things like Ebola, for other viruses, and most recently the coronavirus.

1:15.5

The three coronavirus vaccines that are on the market in the U.S. now, Pfizer, Moderna, and Jansen, also known as J&J, all got emergency use authorization from the Food and Drug Administration.

1:27.2

The whole point of an emergency use authorization is that you can get something to market fast,

1:32.2

even if there are some lingering questions about who it is best for.

1:35.5

As long as the benefits outweigh the risks.

1:38.0

So they still are asking for a certain bar of information about whether it's safe and how effective

1:43.7

it might be.

1:44.6

But for the vaccines, for instance, they only had a few months data when they made those

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Slate Podcasts, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Slate Podcasts and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.